Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 108, Issue 11, Pages 2291-2298
Publisher
Springer Nature
Online
2013-05-22
DOI
10.1038/bjc.2013.247
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro
- (2013) Ilkka Paatero et al. GYNECOLOGIC ONCOLOGY
- Frequent Gene Amplification Predicts Poor Prognosis in Gastric Cancer
- (2012) Jing Shi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A growing family: Adding mutated Erbb4 as a novel cancer target
- (2011) Udo Rudloff et al. CELL CYCLE
- Function ofERBB4is determined by alternative splicing
- (2011) Ville Veikkolainen et al. CELL CYCLE
- Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines
- (2010) Christopher P. Mill et al. EXPERIMENTAL CELL RESEARCH
- Anti-tumor activity of splice-switching oligonucleotides
- (2010) John A. Bauman et al. NUCLEIC ACIDS RESEARCH
- A Therapeutic Opportunity in Melanoma: ErbB4 Makes a Mark on Skin
- (2009) Jeff Settleman CANCER CELL
- ErbB receptors and signaling pathways in cancer
- (2009) Nancy E Hynes et al. CURRENT OPINION IN CELL BIOLOGY
- Nedd4 mediates ErbB4 JM-a/CYT-1 ICD ubiquitination and degradation in MDCK II cells
- (2009) Fenghua Zeng et al. FASEB JOURNAL
- Potential of ErbB4 antibodies for cancer therapy
- (2009) Maija Hollmén et al. Future Oncology
- ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo
- (2009) R. S. Muraoka-Cook et al. MOLECULAR AND CELLULAR BIOLOGY
- Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4
- (2009) Todd D Prickett et al. NATURE GENETICS
- Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms
- (2009) M Hollmén et al. ONCOGENE
- MutatedERBB4: a novel drug target in metastatic melanoma?
- (2009) Kari Kurppa et al. Pigment Cell & Melanoma Research
- RNA repair restores hemoglobin expression in IVS2-654 thalassemic mice
- (2009) S. Svasti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The status and role of ErbB receptors in human cancer
- (2008) I. Überall et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- An Endogenous TNF-α Antagonist Induced by Splice-switching Oligonucleotides Reduces Inflammation in Hepatitis and Arthritis Mouse Models
- (2008) Maria A Graziewicz et al. MOLECULAR THERAPY
- Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms
- (2008) M. Sundvall et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search